Hamad Medical Corporation (HMC), the leading provider of specialist diabetes care in Qatar, continues to advance its commitment to world-class diabetes management through comprehensive, patient-centered care, innovative research, and multidisciplinary expertise."HMC is committed to providing world-class diabetes care that meets the highest international standards," said Director of the Qatar Metabolic Institute Dr. Dabia Al Mohanadi."Through innovation, multidisciplinary expertise, and cutting-edge research, we continue to enhance our services to improve patient outcomes and establish Qatar as a leader in diabetes management in the region," Dr. Al Mohanadi noted.HMC's National Diabetes Centers, located at Hamad General Hospital, Mesaieed Hospital, and the Women's Wellness and Research Center, serve as premier facilities for specialist diabetes care. Designed as one-stop-shop treatment centers, they provide patients with access to expert consultations, individualized treatment plans, medications, and health education.With more than 120,000 patient visits annually, these centers cater to over 30,000 patients, reflecting the growing demand for advanced diabetes care in Qatar.In recognition of HMC's high standards of patient care, safety, and clinical excellence, HMC's National Diabetes Centers have been awarded the Joint Commission International (JCI) Clinical Care Program Certification (CCPC) for diabetes care."Achieving this recognition highlights the dedication of our multidisciplinary teams, who work tirelessly to improve patient outcomes and enhance the quality of care we provide. This certification is a testament to our unwavering commitment to excellence in diabetes care," said Dr. Dabia Al Mohanadi.
February 25, 2025 | 05:51 PM